6533b862fe1ef96bd12c6354
RESEARCH PRODUCT
When GLP-1 hits the liver: a novel approach for insulin resistance and NASH
Yong Ook KimDetlef Schuppansubject
Malemedicine.medical_specialtyCirrhosisPhysiologydigestive systemGastroenterologyGlucagon-Like Peptide-1 ReceptorSimple steatosisInsulin resistanceNon-alcoholic Fatty Liver DiseaseFibrosisPhysiology (medical)Internal medicineNonalcoholic fatty liver diseaseReceptors GlucagonAnimalsMedicineHepatologybusiness.industryDisease progressionGastroenterologynutritional and metabolic diseasesmedicine.diseasedigestive system diseasesSevere inflammationFatty LiverSteatohepatitisPeptidesbusinessdescription
nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum ranging from simple steatosis to steatohepatitis (NASH), increasing fibrosis and eventually, cirrhosis ([22][1]). Importantly, NASH accompanied by fibrosis and severe inflammation is the most relevant predictor for disease progression
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2012-03-03 | American Journal of Physiology-Gastrointestinal and Liver Physiology |